Professor Hisham Mehanna

InHANSE, Institute of Cancer and Genomic Sciences, University of Birmingham

Professor Mehanna is the Chair of Head and Neck Surgery, and Director of InHANSE, at the University of Birmingham.

Hisham’s clinical interests are recurrence head and neck cancer surgery and thyroid and minimal access parathyroid surgery.

Hisham has a keen interest in clinical and translational research, heading a research team of 20 researchers, and holding over £10million in research grants. The main areas of his research are Human Papillomavirus-associated head and neck cancer and thyroid cancer. His research themes are drug development and redeployment, biomarkers of treatment response and early and late phase clinical trials in head and neck cancer. He is chief investigator of several multicentre and multinational clinical trials, including the PET NECK trial, published in the NEJM in 2016.

He is currently President of the British Association of Head Neck Oncologists (BAHNO) and past Chair of the Research Committee of BAHNO, the UK’s multi-disciplinary professional body, and past Chair of the UK’s National Cancer Research Institute’s head and neck group, responsible for all head neck cancer research in the UK.

dont miss

Clinical trials that change patient care and the lessons learnt

We will give examples of studies in head and neck cancer that have changed patient care, and the lessons learnt in running these studies.

EVEN MORE SEMINARS

  • Professor Noel Clarke: Speaking at the Oncology Convention

    Professor Noel Clarke
    The Christie and Salford Royal Hospitals, Manchester UK

    Improving Prostate Cancer Outcomes Through Cancer Trials

  • Mr Hamish Clouston: Speaking at the Oncology Convention

    Mr Hamish Clouston
    The Christie NHS Foundation Trust

    Surgical Management of Advanced Colonic and Rectal Malignancies.

  • Dr Tony Dhillon: Speaking at the Oncology Convention

    Dr Tony Dhillon
    University of Surrey and Royal Surrey County Hospital

    Immunotherapy and Colon Cancer

  • Professor Robert Thomas: Speaking at the Oncology Convention

    Professor Robert Thomas
    Bedford and Addenbrooke's Cambridge University Hospitals

    Evidence based lifestyle strategies after cancer - a research review

  • Dr Abeer Shaaban: Speaking at the Oncology Convention

    Dr Abeer Shaaban
    Queen Elizabeth Hospital Birmingham & University of Birmingham

    Breast Pathology: Assessing tumour response to neoadjuvant chemotherapy and endocrine therapy– Pathological considerations